Skip to main content
SpringerLink
Log in

PPARγ and insulin sensitivity: too much and too little of a good thing

  • Original Article
  • Published:
Journal of Molecular Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Kersten S, Desvergne B, Wahli W (2000) Roles of PPARs in health and disease. Nature 405:421–424

    CAS  Google Scholar 

  2. Okuno A, Tamemoto H, Tobe K, Ueki K, Mori Y, Iwamoto K, Umesono K, Akanuma Y, Fujiwara T, Horikoshi H, Yazaki Y, Kadowaki T (1998) Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats. J Clin Invest 101:1354–1361

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  3. Malinowski JM, Bolesta S (2000) Rosiglitazone in the treatment of type 2 diabetes mellitus: a critical review. Clin Ther 22:1151–1168

    Article  CAS  PubMed  Google Scholar 

  4. Deeb SS, Fajas L, Nemoto M, Pihlajamaki J, Mykkanen L, Kuusisto J, Laakso M, Fujimoto W, Auwerx J (1998) A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet 20:284–287

    Article  CAS  PubMed  Google Scholar 

  5. Stumvoll M, Stefan N, Fritsche A, Madaus A, Tschritter O, Koch M, Machicao F, Häring H. Interaction effect between common polymorphisms in PPARg (Pro12Ala) and IRS-1 (Gly972Arg) on insulin sensitivity. J Mol Med http://dx.doi.org/10.1007/ s001090100282

  6. Almind K, Inoue G, Pedersen O, Kahn CR (1996) A common amino acid polymorphism in insulin receptor substrate- 1 causes impaired insulin signaling. Evidence from transfection studies. J Clin Invest 97:2569–2575

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  7. Burks DJ, White MF (2001) IRS proteins and beta-cell function. Diabetes 50[Suppl 1]:S140–S145

    Article  CAS  PubMed  Google Scholar 

  8. Olefsky JM (2000) Treatment of insulin resistance with peroxisome proliferatoractivated receptor gamma agonists. J Clin Invest 106:467–472

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  9. Yamauchi T, Waki H, Kamon J, Murakami K, Motojima K, Komeda K, Miki H, Kubota N, Terauchi Y, Tsuchida A, Tsuboyama-Kasaoka N, Yamauchi N, Ide T, Hori W, Kato S, Fukayama M, Akanuma Y, Ezaki O, Itai A, Nagai R, Kimura S, Tobe K, Kagechika H, Shudo K, Kadowaki T (2001) Inhibition of RXR and PPARgamma ameliorates diet-induced obesity and type 2 diabetes. J Clin Invest 108:1001–1013

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  10. Busch C, Hegele R (2001) Genetic determinants of type 2 diabetes mellitus. Clin Genet 60:243–254

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Franz-Volhard-Klinik, Humboldt University of Berlin, Wiltbergstrasse 50, 13125, Berlin-Buch, Germany

    Friedrich C. Luft

Authors
  1. Friedrich C. Luft
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Friedrich C. Luft.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Luft, F.C. PPARγ and insulin sensitivity: too much and too little of a good thing. J Mol Med 80, 1–2 (2002). https://doi.org/10.1007/s00109-001-0309-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00109-001-0309-z

Keywords

Search

Navigation